tiprankstipranks
Trending News
More News >
Actinium Pharmaceuticals (DE:7AY1)
FRANKFURT:7AY1
Germany Market

Actinium Pharmaceuticals (7AY1) Income Statement

Compare
1 Followers

Actinium Pharmaceuticals Income Statement

Last quarter (Q1 2025), Actinium Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Actinium Pharmaceuticals's net income was $-15.94M. See Actinium Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 81.00K$ 1.03M$ 1.14M$ 0.00
Gross Profit
$ 0.00$ 81.00K$ 331.00K$ 620.00K$ -447.00K
Operating Expenses
$ 42.12M$ 52.00M$ 35.13M$ 26.11M$ 22.39M
Depreciation and Amortization
$ 811.00K$ 790.00K$ 699.00K$ 524.00K$ 447.00K
EBITDA
$ -37.43M$ -51.13M$ -33.41M$ -24.44M$ -21.77M
Operating Income
$ -42.12M$ -51.92M$ -34.10M$ -24.96M$ -22.39M
Other Income/Expenses
$ 3.88M$ 3.10M$ 1.09M$ 190.00K$ 178.00K
Pretax Income
$ -38.24M$ -48.82M$ -33.02M$ -24.77M$ -22.21M
Net Income
$ -38.24M$ -48.82M$ -31.93M$ -24.58M$ -22.04M
Per Share Metrics
Basic EPS
$ -1.27$ -1.83$ -1.32$ -1.20$ -1.82
Diluted EPS
$ -1.27$ -1.83$ -1.32$ -1.20$ -1.82
Weighted Average Shares Outstanding
30.07M 26.60M 24.14M 20.57M 12.13M
Weighted Average Shares Outstanding (Diluted)
30.07M 26.60M 24.14M 20.57M 12.13M
Currency in USD

Actinium Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis